Author: Hugh Gosling

Inflated descriptions of new cancer drugs, as well as an absence of medical context, may lead to misunderstanding among readers, according to a research letter published in JAMA Oncology.

Pfizer has confirmed that it is in “preliminary friendly discussions with Allergan in relation to a potential transaction”, following intensive media coverage.

Pfizer is in preliminary talks to take over Allergan, according to reports from the Wall Street Journal and Financial Times. The unconfirmed reports follow contact between Pfizer head Ian Read and his counterpart at Allergan, Brent Saunders.

In the wake of a sharp decline in sales of its blockbuster arthritis drug, Remicade, MSD is to offer the NHS discounts and rebates amounting to £48 million on £191 million sales, announced medical affairs director Colin Wheeler last week.

Although most of the UK population is proud of the NHS, older people living with multiple long-term conditions believe the health and care system is not set up to deliver their needs, according to NHS tracking data.